🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07312175
Active, not recruiting Not applicable

3D-Printed Grafts for Knee Cartilage Repair

NCT07312175 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital of Nanchang University
Phase
Not applicable
Started
2025-08-01
Last updated
2025-12-31

Condition(s) studied

Osteochondral Lesions of KneeOsteo Arthritis

Investigational drug(s) / intervention(s)

3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting3D Printing-Assisted Autologous Periosteal-Bone Grafting

3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting: 3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting

3D Printing-Assisted Autologous Periosteal-Bone Grafting: 3D Printing-Assisted Autologous Periosteal-Bone Grafting

Study summary

Research Title:A study on 3D printing-assisted platelet-rich plasma combined with autologous periosteum-bone grafting in the treatment of knee cartilage injury Objectives:(1) To evaluate the accuracy of cartilage damage repair by measuring the chimerism and surface curvature matching degree of 3D printing reconstruction. (2) 3D printing assisted platelerichplasma (PRP) combined with autologous periosteumBone grafting in patients with knee cartilage injury was evaluated for functional and imaging scores to evaluate the clinical effect and cartilage repair effect.

Design Type:Prospective randomized controlled trial Research Objects:Unilateral knee cartilage injury area\>2CM2, international cartilagerepair society (ICRS) grade 3-4 patients Sample size: 60 cases (30 patients with 3D printing-assisted autologous periosteum-bone grafting, 3D printing-assisted PRP combined with autologous periosteum.) - 30 patients with bone grafting).Selection Criteria:(1) Age 18\~65 years old; (2) The body mass index (BMI) is 18\~30kg/m2 ; (3) Knee cartilage injury confirmed by imaging examination, knee cartilage injury 2\>cm2, ICRS grade 3-4; (4) There is no obvious abnormality in the lower limb force line; (5) No other drug injection or surgical treatment has been performed locally in the knee joint in the past 1 year.

Observation indicators:(1) Clinical function(2) Imaging evaluation: Bilateral knee MRI examination was performed on the second day after surgery Statistical analysis methods:SPSS software was used for data analysis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age 18-65 years; 2. Body Mass Index (BMI) 18-30 kg/m²; 3. Imaging-confirmed knee cartilage damage \>2 cm² with International Cartilage Repair Society (ICRS) grade 4; 4. No significant lower limb alignment abnormalities; 5. No prior local drug injections in the knee joint within the past year. Exclusion Criteria: 1. Significant osteoporosis; 2. Individuals with immature bones; 3. Those with poor mechanical alignment; 4. Presence of meniscus injury, cruciate ligament or collateral ligament rupture, or incomplete healing following surgery for any of these conditions; 5. Severe knee joint effusion; 6. Use of corticosteroids or immunosuppressive agents; 7. Poor general health, alcoholism, or substance abuse; 8. Previous treatment with autologous blood products or stem cell preparations.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
330006 Nanchang Jiangxi

More Second Affiliated Hospital of Nanchang University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07312175 on ClinicalTrials.gov ↗ ← All trials in China